Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Inhibition, Psychological × INCB039110 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Pancreatic Neoplasms 1 Lung Neoplasms 1 Inhibition, Psychological 1 Carcinoma, Non-Small-Cell Lung 1 B-Cell Malignancies 1

Interventions

osimertinib 1 itacitinib 1 INCB039110 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02917993 2026-02-09

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Incyte Corporation

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Inhibition, Psychological, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡